Teva Pharmaceutical Industries LtdTEVA:TLV

18,940
10.00 / 0.05%
301.30k
41.98%
0.693
Close in ILAToday's changeShares traded1 year changeBeta
Data delayed at least 20 minutes, as of Sep 17 2014 15:24 BST.

Summary

Teva Pharmaceutical Industries Ltd (TEVA:TLV) set a new 52-week high during Wednesday's trading session when it reached 19,070. Over this period, the share price is up 43.16%.

52-week range
Today
12,800
Nov 05 2013
19,070
Sep 17 2014
Markit short selling activity
Low
Medium
High
Open19,000
Day high--
Day low--
Bid--
Offer--
Previous close18,940
Average volume360.87k
Shares outstanding952.14m
Free float937.71m
P/E (TTM)17.18
Market cap180.88bn ILS
EPS (TTM)11.06 ILS
Annual div (TTM)406.30 ILS
Annual div yield (TTM)2.14%
Div ex-dateAug 21 2014
Div pay-dateSep 04 2014
Data delayed at least 20 minutes, as of Sep 17 2014 15:24 BST.

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Teva Pharmaceutical Industries Ltd+2.60%+5.40%+8.04%+41.98%-2.12%
TASE TA-100 IDX+0.94%+4.36%+0.96%+15.23%+42.34%
IL/HEALTH CARE+1.53%+3.54%+9.13%+29.57%--
IL/PHARMACEUTICALS+1.53%+3.54%+9.13%+29.57%--
Data delayed at least 20 minutes, as of Sep 17 2014 15:24 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.